Cooperative Agreement Program for the National Academic Centers of Excellence on Youth Violence Prevention; Notice of Availability of Funds-Amendment, 5685 [05-2044]

Download as PDF Federal Register / Vol. 70, No. 22 / Thursday, February 3, 2005 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Funding Opportunity Number: CE05–018] Cooperative Agreement Program for the National Academic Centers of Excellence on Youth Violence Prevention; Notice of Availability of Funds-Amendment A notice announcing the availability of fiscal year (FY) 2005 funds for cooperative agreements to to establish up to ten National Academic Centers of Excellence (ACE) on Youth Violence Prevention, serving as national models for the prevention of youth violence, was published in the Federal Register on November 22, 2004, Vol. 69, No. 224, pages 67915–67930. The notice is amended as follows: On page 67917, Column 3, Section IV.1. Address to Request application Package, delete the first sentence and replace with ‘‘To apply for this funding opportunity, use application form PHS 398 (OMB number 0925–0001 rev. 9/2004). Dated: January 28, 2005. William P. Nichols, Director, Procurement and Grants Office, Centers for Disease Control and Prevention. [FR Doc. 05–2044 Filed 2–2–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institute for Occupational Safety and Health; Advisory Board on Radiation and Worker Health In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), and pursuant to the requirements of 42 CFR 83.15(a), the Centers for Disease Control and Prevention (CDC) has announced the following committee meeting where petitions for designation of classes of employees as members of the Special Exposure Cohort (SEC) will be considered for the Mallinckrodt Destrehan Street Plant and the Iowa Army Ammunition Plant. Name: Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH). Committee Meeting Times and Dates: 1 p.m.–5 p.m., February 7, 2005, 8 a.m.–4:45 p.m., February 8, 2005, 7 p.m.–8:30 p.m., February 8, 2005, 8:30 a.m.–4:30 p.m., February 9, 2005. VerDate jul<14>2003 19:18 Feb 02, 2005 Jkt 205001 Place: Adam’s Mark St. Louis, 4th and Chestnut Street, St. Louis, Missouri 63102, telephone (314) 241–7400, fax (314) 241– 9839. Status: Open to the public, limited only by the space available. The meeting space accommodates approximately 500 people. Matters to be Discussed: This notice provides further information regarding two items on the agenda for this meeting. First, NIOSH is seeking the ABRWH’s guidance on dealing with dose reconstruction data when questions are raised about the authenticity and reliability of the data. Second, NIOSH is seeking guidance from the ABRWH on the findings of the SEC Petition Evaluation Reports—Mallinckrodt Chemical Company, Destrehan Street Plant, the entire uranium division, 1942–1957, St. Louis, Missouri, and Petitioners Comments on Report; and the NIOSH SEC Petition Evaluation Report— Iowa Army Ammunition Plant (IAAP), Line 1 and associated areas, 1947–1974, Burlington, Iowa, and Petitioners Comments on Report. The NIOSH SEC Petition Evaluation Report for Mallinckrodt 1942– 1945 and for Mallinckrodt 1946–1957 find that radiation doses cannot be estimated with sufficient accuracy and that there is a reasonable likelihood that such radiation dose may have endangered the health for Mallinckrodt Chemical Company, Destrehan Street Plant uranium division employees from 1942–1948. The NIOSH SEC Petition Evaluation Report for Mallinckrodt 1946– 1957 finds that dose reconstructions may or may not be feasible from 1949–1957. NIOSH also seeks the guidance of the ABRWH on the NIOSH SEC Petition Evaluation Report— Iowa Army Ammunition Plant that finds that records and/or information necessary to publicly evaluate part of the IAAP SEC Petition are not, and will not be available on a transparent and timely basis. In the event an individual cannot attend, written comments may be submitted. Any written comments received will be provided at the meeting and should be submitted to the contact person below well in advance of the meeting. Contact Person for More Information: Lewis Wade, Senior Science Advisor to the Director, NIOSH, CDC, 200 Independence Avenue, SW., Room 717H, Washington, DC 20201, telephone (202) 401–6997; fax (202) 205–2207. Dated: February 1, 2005. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention (CDC). [FR Doc. 05–2201 Filed 2–1–05; 2:22 pm] BILLING CODE 4163–19–P PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 5685 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Draft Acute Injury Care Research Agenda for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: Draft Acute Injury Care Research Agenda for the National Center for Injury Prevention and Control. ACTION: SUMMARY: The Centers for Disease Control and Prevention (CDC) announces the availability of the Draft Acute Injury Care Research Agenda for the National Center for Injury Control and Prevention (NCIPC) and solicits comments during the public comment period of February 3, 2005, through March 3, 2005. In June 2002, NCIPC released its current Injury Research Agenda, which outlines the Center’s injury research direction through 2007. The NCIPC Research Agenda highlights seven key injury research areas: Injuries at home and in the community, recreation, transportation, violence, suicide, youth violence, and acute care, disability, and rehabilitation. The NCIPC Research Agenda was being completed when the events of September 11, 2001, occurred; that event led NCIPC to revisit the agenda and see what, if any, gaps existed and needed to be addressed. This analysis revealed that out of the thirteen priority areas for research in the area of acute care, disability, and rehabilitation, only three dealt specifically with acute injury care. Recognizing this limited focus, the NCIPC decided to supplement the current research agenda by extending the acute injury care portion of the agenda, focusing on the intersection between public health and acute injury care research. Over the past year, NCIPC has been developing an Acute Injury Care Research Agenda based on input from external experts in the field of acute injury care (e.g., emergency medical services, emergency medicine, trauma surgery, public health), Federal partners, and internal staff. The objectives presented will be appended to the acute care section of the NCIPC Research Agenda. The proposed six research objectives and four infrastructure objectives are as follows: E:\FR\FM\03FEN1.SGM 03FEN1

Agencies

[Federal Register Volume 70, Number 22 (Thursday, February 3, 2005)]
[Notices]
[Page 5685]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-2044]



[[Page 5685]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Funding Opportunity Number: CE05-018]


Cooperative Agreement Program for the National Academic Centers 
of Excellence on Youth Violence Prevention; Notice of Availability of 
Funds-Amendment

    A notice announcing the availability of fiscal year (FY) 2005 funds 
for cooperative agreements to to establish up to ten National Academic 
Centers of Excellence (ACE) on Youth Violence Prevention, serving as 
national models for the prevention of youth violence, was published in 
the Federal Register on November 22, 2004, Vol. 69, No. 224, pages 
67915-67930.
    The notice is amended as follows:
    On page 67917, Column 3, Section IV.1. Address to Request 
application Package, delete the first sentence and replace with ``To 
apply for this funding opportunity, use application form PHS 398 (OMB 
number 0925-0001 rev.
9/2004).

    Dated: January 28, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention.
[FR Doc. 05-2044 Filed 2-2-05; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.